Quite often in stock markets, companies that offer something novel and unique attract speculators. So, when Crispr Therapeutics AG(NASDAQ: CRSP ) quadrupled from 52-week lows, investors naturally questioned its valuation against its prospects.
After Soaring to New Highs, Crispr Therapeutics AG Stock Ripe for a Fall
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться